Cardiovascular disease and risk in COPD: a state of the art review.
Ricardo PolmanJohn R HurstOmer Faruk UysalSwapna MandalDominik LinzSami SimonsPublished in: Expert review of cardiovascular therapy (2024)
The prospective identification of co-morbid COPD in CVD patients and of CVD and CV risk in people with COPD is crucial for optimizing clinical outcomes. This includes the identification of novel treatment targets and the design of clinical trials specifically designed to reduce the cardiovascular burden and mortality associated with COPD. Databases searched: Pubmed, 2006-2024.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- cardiovascular disease
- clinical trial
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- cardiovascular events
- bariatric surgery
- prognostic factors
- cystic fibrosis
- peritoneal dialysis
- coronary artery disease
- patient reported outcomes
- combination therapy
- deep learning
- weight loss
- study protocol
- replacement therapy